Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole + Flucytosine for Early Cryptococcal Infection
NCT01562132Phase 2Terminated
- Sponsor
- Yale University
- Start
- Sep 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flucytosine in cryptococcosis, sponsored by Yale University. Started Sep 2013; status: terminated.
02
Drugs
flucytosine
03
Conditions
cryptococcosis
Beyond the preview
Go deeper on NCT01562132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01562132.